GBM is assigned WHO grade IV [4], and recently, the classification has been refined, with diagnosis based not only on histology but also on several molecular markers such as isocitrate dehydrogenase (IDH) and epidermal growth factor receptor (EGFR) [5]. This evidence concerns the gene EGFR and glioblastoma.